OmniAb, Inc.(OABI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,406 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in OABI
Events flagged as statistical outliers against OABI's own multi-year baseline — not fixed dollar thresholds.
- Score shock2026-08-07
OABI quality score jumped 13 points (10→23) on a new filing
View source filing →
OABI Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for OmniAb, Inc. (OABI), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OABI at 33.0/100 on a 32-signal composite quality model, placing it at rank #2,406 of 2,962 stocks — the bottom half of the AI-ranked universe. OABI scores in the top quartile across revenue growth (85.9). Areas of concern include revenue scale (7.0) and profitability (7.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 3.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), OmniAb, Inc. reports quarterly revenue of $13.4M, net income of $-5.9M, free cash flow of $2.6M. Top institutional holders of OABI by reported 13-F value include Whitefort Capital Management, BlackRock, NOMURA, based on the most recent SEC filings. OABI trades on the Nasdaq exchange and files with the SEC under CIK 1846253. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OABI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OmniAb, Inc. directly from SEC EDGAR. OmniAb, Inc.'s 13F Pro composite quality score has ranged between 6 and 43 since 2023, currently 33.0 — a stable long-term trajectory across 60 quarterly and live scoring snapshots.
Revenue
Q2 2026
$13.4M
Net Income
Q2 2026
$-5.9M
Free Cash Flow
Q2 2026
$2.6M
ROIC
Q2 2026
-10.2%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-29.3% YoYNet Income
-4.4% YoYOperating Income
+7.4% YoYEPS (Diluted)
+6.6% YoYTotal Assets
-7.6% YoYOp. Cash Flow
+8.1% YoYFree Cash Flow
+10.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $18.7M -29.3% | $26.4M -22.8% | $34.2M -42.2% | $59.1M +70.0% | $34.7M | — |
| Net Income | $-64.8M -4.4% | $-62.0M -22.5% | $-50.6M -126.6% | $-22.3M +17.4% | $-27.0M | — |
| Operating Income | $-69.0M +7.4% | $-74.5M -7.3% | $-69.4M -160.5% | $-26.6M +25.2% | $-35.6M | — |
| EPS (Diluted) | $-0.57 +6.6% | $-0.61 -19.6% | $-0.51 -96.2% | $-0.26 +21.2% | $-0.33 | — |
| Total Assets | $300.9M -7.6% | $325.6M -13.2% | $375.2M -10.9% | $421.2M +78.0% | $236.7M | — |
| Operating Cash Flow | $-36.5M +8.1% | $-39.7M -1790.0% | $2.3M +165.4% | $-3.6M +36.8% | $-5.7M | — |
| Free Cash Flow | $-37.0M +10.9% | $-41.5M -6008.8% | $703.0K +103.4% | $-20.8M -113.0% | $-9.7M | — |
Get alerted when OABI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for OmniAb, Inc. including:
Top Institutional Holders of OABI
Whitefort Capital Management, LP
$25.2M10,248,658 shBlackRock, Inc.
$21.9M8,897,490 shNOMURA HOLDINGS INC
$12.4M5,028,160 shCADIAN CAPITAL MANAGEMENT, LP
$10.4M4,211,821 shVANGUARD CAPITAL MANAGEMENT LLC
$9.5M3,852,356 shGEODE CAPITAL MANAGEMENT, LLC
$7.1M2,883,978 shRICE HALL JAMES & ASSOCIATES, LLC
$6.4M2,610,434 shPRIVATE MANAGEMENT GROUP INC
$5.8M2,344,770 shSTATE STREET CORP
$5.2M2,133,549 shDIMENSIONAL FUND ADVISORS LP
$3.1M1,262,099 sh
| Fund | Value | Shares |
|---|---|---|
| Whitefort Capital Management, LP | $25.2M | 10,248,658 |
| BlackRock, Inc. | $21.9M | 8,897,490 |
| NOMURA HOLDINGS INC | $12.4M | 5,028,160 |
| CADIAN CAPITAL MANAGEMENT, LP | $10.4M | 4,211,821 |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.5M | 3,852,356 |
| GEODE CAPITAL MANAGEMENT, LLC | $7.1M | 2,883,978 |
| RICE HALL JAMES & ASSOCIATES, LLC | $6.4M | 2,610,434 |
| PRIVATE MANAGEMENT GROUP INC | $5.8M | 2,344,770 |
| STATE STREET CORP | $5.2M | 2,133,549 |
| DIMENSIONAL FUND ADVISORS LP | $3.1M | 1,262,099 |
Companies Similar to OABI
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
BICYCLE THERAPEUTICS PLC
Janux Therapeutics, Inc.
SI-BONE, Inc.
Invivyd, Inc.
NeuroPace Inc
Coherus Oncology, Inc.
Kura Oncology, Inc.
PRECIGEN, INC.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put OABI on your watchlist
Track score changes the day OmniAb, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OABI a good stock to buy?
13F Pro's AI-powered analysis of OmniAb, Inc. (OABI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OABI are available on the OABI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. OABI is classified as a small company.
Which hedge funds own OABI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OABI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OmniAb, Inc.'s investment landscape.